Gal-3 inhibition by TD139, a high-affinity galectin-3 inhibitor, attenuates β-catenin activation and reduces fibrosis in an animal model of bleomycin-induced lung fibrosis [55]. Here, LGALS3 is linked to pulmonary fibrosis.